Skip to main content
. 2024 Dec 16;18(12):e70041. doi: 10.1111/crj.70041

FIGURE 2.

FIGURE 2

The initial PET/CT scans and CT scans before and after treatment of Case 2. (A) CT scans of Case 2 before and after treatment. Ensartinib: 225 mg orally per day; PC, pemetrexed + carboplatinum; PD, progressive disease; PR, partial remission. (B) Initial PET/CT scans of Case 2. The red arrows point to the primary lung cancer, metastatic lymph node, and metastatic lesions. Lorlatinib: 100 mg orally per day.